ImClone Systems News

The Kids Cancer Foundation of South Florida and ImClone Systems Inc., a national oncology pharmaceutical company, held a Family Fun Event on Friday, June 27 at Okeeheelee Park for local kids with cancer.

Some companies are obviously great investments -- in hindsight. Sure, we should have bought Starbucks at its IPO and earned huge returns over the years.

MOST NOTEWORTHY: The North American Pipeline sector, Aeropostale and ImClone were today's noteworthy initiations: OTHER INITIATIONS: When you enter your name and email address, you'll be sent a link to confirm ...

Main Category: Cancer / Oncology Also Included In: Clinical Trials / Drug Trials Article Date: 27 Jun 2008 ImClone Systems Incorporated , a global leader in the development and commercialization of novel ...

A trial judge in New York recently granted plaintiff C. Richard Stafford summary judgment, holding that his former employer breached his employment contract by failing to make severance payments.

Celebrity homemaker Martha Stewart has been denied entry to Britain because of her 2004 U.S. conviction for lying about a stock sale.

Fool contributor and health-care sector editor Brian Orelli is hanging out at the Bio International Convention this week.

Millard had been president of the media division and Marino had headed merchandising, Martha Stewart Living said in a statement today.

CHICAGO : Two biotechnology giants did battle here at the largest U.S. cancer conference over the weekend.

BMY / DNA / IMCL One of the pharmaceutical industry's biggest and most high profile society conferences is the American Society of Clinical Oncology, or ASCO, meeting.

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.

The CBOE volatility index, also known as the VIX, ended the day at 17.83, down nearly 2% from Thursday's close of 18.14. Vancouver-based women's athletic wear maker Lululemon Athletica is posting earnings today ...

New cancer research is moving medicine closer to more reliable use of genetic tests to help decide which drugs to use -- good news for patients, but potentially less lucrative for drug companies.

Interview with CEO John Johnson

This improvement in survival was observed across all histological subtypes, patient performance status , age groups, previous smoking history, and gender.

ImClone Systems Inc. 's only drug, Erbitux, extended life by 1.2 months for lung cancer patients in a study that may help partners Bristol-Myers Squibb Co.

The Sidewinder Report , the www.onn.tv daily options news program recorded live on the floor of the Chicago Board Options Exchange, today examined options trading in the following securities: Anheuser-Busch ...

Potential advances in the treatment of lung cancer, the leading cause of cancer deaths in the United States, will be a major focus at a key meeting of oncology specialists starting on Friday.

Biotech aficionados have waited since September 2007 to find out just how many weeks of survival ImClone's IMCL Erbitux can offer to patients with advanced non-small cell lung cancer, particularly a ...

It's fun to peruse the Form 13-Fs of the most successful investors . Not only can you get investment ideas, but if you're an activist investor, you can get a sneak peek at the next company your favorite ...